Skip to main content
. 2020 Aug 1;40(12):3469–3479. doi: 10.1007/s10792-020-01533-y

Table 3.

Meibomian gland loss of the upper eyelid in OMGD and HMGD subjects

Degree OMGD HMGD
0 0% (0/25) 0% (0/25)
1 64% (16/25) 52% (13/25)
2 36% (9/25) 44% (11/25)
3 0% (0/25) 4% (1/25)